ChemicalBook > Product Catalog >Biochemical Engineering >Inhibitors >BIBF-1120

BIBF-1120

BIBF-1120 Structure
CAS No.
928326-83-4
Chemical Name:
BIBF-1120
Synonyms
CS-76;BIBF-1120;Nintedanib;Trinidad Neeb;VargatefTM BIBF;Nintedanib, >=98%;BIBF-1120(Vargatef);BIBF1120 nintedanib;Intedanib(BIBF-1120);928326-83-4 BIBF-1120
CBNumber:
CB92467147
Molecular Formula:
C31H33N5O4
Molecular Weight:
539.633
MOL File:
928326-83-4.mol
MSDS File:
SDS
Modify Date:
2024/5/27 11:17:44

BIBF-1120 Chemical Properties,Uses,Production

Description

BIBF 1120 is a triple kinase inhibitor blocking vascular endothelial growth factor receptor, PDGF receptor, and FGF receptor, which has a potential to inhibit tumor growth and pulmonary fibrosis.

Characteristics

Primary targets: PDGFR; VEGFR; FGFR
Class: receptor tyrosine kinase
Treatment: ILD, IPF
Oral bioavailability = 4.7%
Elimination half-life = 10

brand name

OfevTM

Anticancer Research

BIBF 1120 is a potent inhibitor of VEGFR as well as PDGF and fibroblast growth factor receptor. In a randomized phase II placebo-controlled trial, patients who had just completed chemotherapy for relapsed ovarian cancer, with evidence of response, but at high risk of further early recurrence were treated with BIBF 1120. The study drug was taken continuously (28-day cycles) for 9 cycles (36 weeks) or until disease progression or patient withdrawal. The 36-week PFS 26-week rates were 16.3% and 5.0% in the BIBF 1120 and placebo groups, respectively (HR 0.65; 95% Cl, 0.42 to 1.02; P = .06). Toxicity was also well tolerated.This has prompted a phase III trial (NCTO1O15118) where BIBF 1120 will be combined with carboplatin/paclitaxel as front-line chemotherapy in ovarian cancer.

Side effects

Most of the adverse effects associated with BTBF-1120 were tolerable. They include diarrhea, nausea, vomiting, abdominal pain, and reversible increase in liver enzymes.

BIBF-1120 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 164)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Shaanxi TNJONE Pharmaceutical Co., Ltd +8618740459177 China 1143 58 Inquiry
Capot Chemical Co.,Ltd. 571-85586718 +8613336195806 China 29798 60 Inquiry
ATK CHEMICAL COMPANY LIMITED +undefined-21-51877795 China 32836 60 Inquiry
Zhejiang ZETian Fine Chemicals Co. LTD +8618957127338 China 2136 58 Inquiry
Shenzhen Nexconn Pharmatechs Ltd +86-755-89396905 +86-15013857715 China 10311 58 Inquiry
Shanghai Yingrui Biopharma Co.,Ltd 21-33585366 CHINA 1320 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29824 58 Inquiry
Fuxin Pharmaceutical +86-021-021-50872116 +8613122107989 China 10297 58 Inquiry
Baoji Guokang Bio-Technology Co., Ltd. 0917-3909592 13892490616 China 9316 58 Inquiry
Zhejiang J&C Biological Technology Co.,Limited +1-2135480471 +1-2135480471 China 10522 58 Inquiry

Related articles

BIBF-1120 BIBF-1120(Vargatef) VARGATEF ( BIBF1120 ) Vargatef Base or BIBF-1120 BIBF1120,BIBF-1120,Vargatef VargatefTM BIBF 928326-83-4 BIBF-1120 Nintedanib Esylate(BIBF-1120) Nintedanib, >=98% Trinidad Neeb CS-76 Intedanib(BIBF-1120) BIBF1120 (VARGATEF|Nintedanib) BIBF1120 nintedanib Nintedanib 928326-83-4 API